Can a patient who has been stable on testosterone cypionate (testosterone cypionate) once weekly be switched to testosterone undecanoate (testosterone undecanoate) if testosterone cypionate is unavailable?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Testosterone Cypionate to Testosterone Undecanoate

Yes, you can switch your patient from weekly testosterone cypionate to testosterone undecanoate, but the dosing regimen and administration requirements are completely different and require careful attention to the specific protocol.

Critical Differences Between Formulations

Testosterone Cypionate (Current Regimen)

  • Your patient is likely receiving 50-100 mg weekly via intramuscular injection, which can be self-administered in the thigh or given by another person in the gluteal region 1
  • This provides relatively stable testosterone levels with weekly dosing 1, 2

Testosterone Undecanoate (Replacement Option)

  • Must be administered as 750 mg initially, followed by 750 mg at 4 weeks, then 750 mg every 10 weeks thereafter 1
  • Must be administered as gluteal intramuscular injection ONLY - this cannot be self-administered in the thigh like cypionate 1
  • The volume is 3 mL per injection, which is the maximum safe volume for gluteal IM injection 1
  • Provides fewer yearly injections (approximately 4-5 per year after loading) with less fluctuation in testosterone levels compared to biweekly cypionate dosing 1

Conversion Protocol

Initial Dosing Schedule

  • First injection: 750 mg (3 mL) gluteal IM 1
  • Second injection: 750 mg at 4 weeks 1
  • Maintenance: 750 mg every 10 weeks 1

Monitoring Requirements

  • Measure testosterone levels 2-3 months after initiating undecanoate, targeting mid-normal values of 450-600 ng/dL 1, 2
  • For undecanoate, check levels before the next scheduled injection (at trough) 1
  • Once stable, monitor every 6-12 months 1
  • Continue monitoring hematocrit/hemoglobin and PSA as with any testosterone therapy 2

Important Clinical Considerations

Advantages of Testosterone Undecanoate

  • Long-acting formulation requiring only 4-5 injections per year after loading 3, 4
  • Provides stable testosterone levels for 12 weeks 5
  • Excellent safety profile with no serious side effects noted in long-term studies up to 8 years 3
  • May improve patient compliance due to convenient dosing schedule 3, 4

Critical Limitations and Caveats

  • Cannot be self-administered - requires healthcare provider or trained person to give gluteal injections 1
  • Requires 1.5 inch needle for proper gluteal administration 1
  • More expensive than testosterone cypionate (though fewer injections may offset some cost) 1
  • The 3 mL volume must be administered in the gluteal site only; this volume is too large for other sites 1

Common Pitfalls to Avoid

  • Do not attempt to use the same weekly dosing schedule - undecanoate has completely different pharmacokinetics requiring the specific 750 mg loading and maintenance protocol 1, 6
  • Do not allow thigh self-administration - the 3 mL volume and formulation characteristics require gluteal administration only 1
  • Do not skip the 4-week loading dose - the initial dose followed by a second dose at 4 weeks is essential to achieve steady-state levels before transitioning to 10-week intervals 1, 6
  • Do not assume interchangeability with cypionate dosing - these are fundamentally different formulations with distinct administration requirements 5, 7

Practical Implementation

If your patient requires self-administration capability or prefers more frequent but smaller injections, testosterone cypionate (or enanthate) remains the better choice. However, if the patient has access to healthcare administration every 10 weeks and values fewer injections, testosterone undecanoate is an excellent alternative with proven long-term safety and efficacy 3, 4.

References

Guideline

Testosterone Replacement Therapy Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intramuscular Testosterone Dosing for Low Testosterone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Testosterone undecanoate in the treatment of male hypogonadism.

Expert opinion on pharmacotherapy, 2010

Research

Advances in testosterone replacement therapy.

Frontiers of hormone research, 2009

Research

Emerging medication for the treatment of male hypogonadism.

Expert opinion on emerging drugs, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.